• Muhammad Tariq Mehr Department of Medicine, Hayatabad Medical Complex, Peshawar
  • Sidra Humayun Department of Pathology, Muhammad College of Medicine, Peshawar, Pakistan
  • Qamar Un Nisa Department of Obstetrics and Gynaecology, Rehman Medical Institute, Peshawar
  • Shehrbano Raza Hayatabad Medical Complex, Peshawar
  • Ali Qaisar Jadoon United Medical and Dental College, Karachi
  • Ghulam Farooq Department of Medicine, Pak International Medical College, Peshawar



VTE Prophylaxis, Anticoagulation, Compression Stockings


Background: Venous thromboembolism (VTE) prevention in hospitalized patients is primarily based on adequate risk stratification, but the recommended prophylaxis for associated risk factors are not adequately utilized. Objective was to estimate the implementation of the standard international VTE prophylaxis guidelines in acutely ill patients in medical wards of Hayatabad Medical Complex (HMC), Peshawar. Methods: This study was conducted in HMC (1st April to 31st December, 202), to determine the proportion of patients receiving appropriate VTE prophylaxis according to ANZ WP recommendations, based on their risk profiles. The modalities employed for prevention were Compression Stockings alone, Anticoagulation alone or use of both. Random sampling technique allowed inclusion of 600 patients from medicine department, HMC. Results: Out of the 600 patients, 336 were female while 264 were male. Patients stratified as High Risk were 72% while 28% as Low Risk group. Risk factors observed were age >60 years (43.05), past history of stroke with neurological deficits (64.12%), admission with lung disorders (18.05%) and those with active cancers 6.01%. A total of 57.6% were found to be receiving VTE prophylaxis with 54.2% in High Risk group while 45.8% in low risk group. Amongst the patients receiving VTE prophylaxis, 20.80% patients were receiving both modalities, 49.30 were having TED Stockings alone, while 29.90% were receiving anticoagulation alone. Conclusion: The international standard guidelines for thromboprophylaxis were observed to be poorly followed in our hospital which calls for strategies to identify high risk individuals and initiation of appropriate prophylaxis. 

Pak J Physiol 2023;19(1):29–32


Download data is not yet available.


Tran HA, Gibbs H, Merriman E, Curnow JL, Young L, Bennett A, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust 2019;210(5):227–35.

Galloway J, Barrett K, Irving P, Khavandi K, Nijher M, Nicholson R, et al. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study. RMD open 2020;6(3):e001392.

Secemsky EA, Rosenfield K, Kennedy KF, Jaff M, Yeh RW. High burden of 30?day readmissions after acute venous thromboembolism in the United States. J Am Heart Assoc 2018;7(13):e009047.

Yaria J, Gil A, Makanjuola A, Oguntoye R, Miranda JJ, Lazo-Porras M, et al. Quality of stroke guidelines in low-and middle-income countries: A systematic review. Bull World Health Organ 2021;99(9):640–52E.

Holmes CE, Ades S, Gilchrist S, Douce D, Libby K, Rogala B, et al. Successful model for guideline implementation to prevent cancer-associated thrombosis: venous thromboembolism prevention in the ambulatory cancer clinic. JCO Oncol Pract 2020;16(9):e868–74.

Zhao W, McArthur A, Yu Z, Hu Y, Luo J. Prevention of venous thromboembolism in postoperative abdominal patients: a best practice implementation project. JBI Database System Rev Implement Rep 2018;16(9):1887–901.

Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 2021;5(4):927–74.

Abboud J, Abdel Rahman A, Kahale L, Dempster M, Adair P. Prevention of health care associated venous thromboembolism through implementing VTE prevention clinical practice guidelines in hospitalized medical patients: a systematic review and meta-analysis. Implement Sci 2020;15(1):49.

Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Euro Heart J 2018;39(47):4208–18.

Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 2004;57(12):1254–7.

Hwang HG, Kim YK, Kim MS, Lim GI, Schulman S. Prophylaxis of venous thromboembolism in patients with infectious disease. Tuberc Respir Diseases 2020;83(3):255–6.

Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371(9610):387–94.

Edeer AD, Comez S, Damar HT, Savci A. Prevalence and risk factors of venous thromboembolism in postoperative patients: A retrospective study. Pak J Med Sci 2018;34(6):1539–44.

Kahn SR, Diendéré G, Morrison DR, Piché A, Filion KB, Klil-Drori AJ, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open 2019;9(5):e024444.

Wiercioch W, Nieuwlaat R, Akl EA, Kunkle R, Alexander KE, Cuker A, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv 2020;4(10):2351–65.

Al-Mugheed K, Bayraktar N, Nashwan AJ, Al-Bsheish M, AlSyouf A, Jarrar M. Compliance of non-pharmacological preventive practice of venous thromboembolism among Jordanian nurses. Medicine 2022;101(44):e31189.

Goldin M, Cohen J, Makhnevich A, Mulvany C, Akerman M, Sinvani L. Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study. J Thromb Thrombolysis 2018;45(3):369–76.

Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM, et al. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 2019;173:166–71.

Galanaud JP, Sevestre MA, Genty C, Kahn SR, Pernod G, Rolland C, et al. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014;12:436–43.

Eck RJ, Elling T, Sutton AJ, Wetterslev J, Gluud C, van der Horst ICC, et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis. BMJ 2022;378:e070022.

Mahlab-Guri K, Otman MS, Replianski N, Rosenberg-Bezalel S, Rabinovich I, Sthoeger Z. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: a real life experience. Medicine 2020;99(7):e19127.




How to Cite

Mehr MT, Humayun S, Nisa QU, Raza S, Jadoon AQ, Farooq G. COMPLIANCE WITH STANDARD THROMBOPROPHYLAXIS GUIDELINES AGAINST VENOUS THROMBOEMBOLISM IN ACUTE MEDICAL WARDS —A SINGLE CENTRE EXPERIENCE. Pak J Phsyiol [Internet]. 2023 Mar. 31 [cited 2024 Jul. 23];19(1):29-32. Available from: